IRB forms and submissions requirements
Where & How to Submit to the IRB
Location & Office Hours
IRB Administration Office
87 E. Canfield, 2nd Floor
Detroit, MI 48201
Hours: Monday - Friday, 8:30am - 5:00pm
CLOSED 12:00pm - 1:00pm (for lunch)
Note: The IRB Administration Office follows the WSU closure schedule.
The IRB Administration Office will close Friday July 3, 2020 for the Independence Holiday
The IRB will resume regular remote working business hours on Monday July 6th 8:30 am – 5:00 pm
COVID-19 IRB Submissions UPDATE
The IRB Administration Office is not accepting in-person visits or paper submissions until further notice.
For non-eProtocol submissions please see the following:
Electronic Signature & Attestation (update 7/2020)
The Electronic signature & Attestation and the Additional Key Personnel forms should be opened and completed as an Adobe Acrobat document.
Need information regarding submitting a COVID-19 modification or new submission see the following:
COVID-19 IRB Submission Guidance (updated 4/24/2020)
Note: COVID-19 focused research must first be submitted to the COVID-19 Research Advisory Committee
How do I submit to the COVID-19 Research Advisory Committee?
The Principal Investigator should email the following documents to: COVID19Research@wayne.edu
What should be emailed to the COVID-19 Research Advisory Committee?
- Brief summary of the proposal and protocol
- P.I. name, contact information and affiliation
- Informed consent (if applicable)
- Confirmation of Department Chair approval (can be in the form of an email from the department chair)
Phased Resumption of Research Activities
Whenever possible, research should maintain remote study interventions/visits, as per IRB approval. All changes made to the research protocol and procedures to conduct study interventions/visits remotely must be submitted to the IRB in an amendment before those changes can be implemented.
Only research that can provide a potential direct benefit to the participant may resume with in-person visits at this time. The resumption of in-person research activities with a direct benefit requires informing participants of the resumption, implementation of COVID-19 mitigation precautions taken for in-person visits, and informing participants of those precautions.
Phased Resumption of Research Documents:
Telephone Script (new) used to contact participants before an in-person visit)
Participant Information Sheet (new) used to mail or email to participants before an in-person visit
Phased Resumption of Research Submission Instructions:
Full Board Submissions
Expedited Amendment Submissions
If the study was initially reviewed and approved by the Full Board, the Resumption of Clinical-In Person Research amendment will need to be a Full Board amendment. Please review the IRB Meeting Dates and Deadlines schedule for submission to the appropriate IRB committee. This schedule can be found at https://research.wayne.edu/irb/meetings-deadlines
If the study was initially reviewed and approved as an expedited or exempt submission the Resumption of Clinical In-Person Research amendment will need to be submitted as an expedited amendment.
Please note that if upon review of the amendment it is determined that the study is no longer minimal risk, the IRB Administration Office will contact the PI with instructions to submit as a full board study.
Initial Submissions: Full Board, Expedited, Exempt
Appendix N: Resumption of Clinical In-Person Research must be submitted for all research studies in which activities will include in person visits.
At this time in-person study visits are allowed for research with a direct benefit to participants.
Phased Resumption of Research How to Submit?
Paper-Based Submissions (Non-eProtocol)
See Mitigation Plan above
Amendments: VA and studies not submitted/approved via eProtocol:
Initial/New Submissions VA ONLY:
All documents including Appendix N must be clearly labeled, placed in a zip file with the PI's name and IRB number (for amendments) and submitted to: eIRBManager@wayne.edu.
External IRB Submissions
Initial and Modifications Submit Appendix N (and COVID-19 Participant Information Sheet and Phone Scripts if there will be in person study visits) with the Modification Request Form
to the appropriate email box:
NOTE: An amendment submission of Appendix N is not required if research activities are being conducted in a Clinical Care location/hospital and that institution's COVID-19 Standard Operating Procedures (SOPs) includes a plan to:
(a) Inform participants/patients, staff and visitors about COVID-19 risks;
(b) Screen participants/patients, staff and visitors for COVID-19 symptoms;
(c) Provide guidance for the conduct of person to person visits that includes social distancing, PPE, handwashing and disinfection.
eProtocol Submission Instructions
Full Board, Expedited, & Exempt New/Initial Submissions Now Accepted via eProtocol (excluding VA)
IRB eProtocol Submission Tips
Don't Forget to "Submit Form" for review!
Note: Submissions approved before the implementation of eProtocol will continue to use the applicable forms available on the IRB's website below.
IRB Pre-Review Service & Self Review Tool
The IRB is excited to provide pre-review of initial full board study submissions! The IRB is piloting offering a pre-review of submission documents before submission to the full board. In addition, the IRB now has a Self Pre-Review Assessment Tool that can be used prior to IRB submission. This service is part of a pilot project aimed at improving overall completeness of new study submissions by providing investigator support.
- Complete the Protocol Summary Form, Protocol/Proposal, Consents/Assents, and all other application documents
- Submit documents to: IRBQuestions@wayne.edu The subject line stating: "Pre-Review"
- For eProtocol submissions complete the submission and email IRBQuestions@wayne.edu with "Pre-Review" and the subject line and the IRB Number
- Submit pre-review request at least 2 weeks prior to the IRB submission deadline you are aiming for to give enough time address the pre-reviewer's recommendations.
- Pre-review requests will be reviewed in the order in which they are received.
- At the conclusion of the pre-review an acknowledgement letter will be sent to the submitter listing the documents that have been received, reviewed, along with a stamped pre-review checklist.
- The Pre-Review Acknowledgement Letter and stamped Pre-Review Checklist must be included in the final submission package for the full board's deadline.
New Self Assessment Pre-Review Tool
The Self Assessment Pre-Review tool is useful for completing before submitting to the IRB. The tool walks you through the submission requirements based on the many different scenarios unique to each study. This tool can be used as part of the IRB pre-review or used solely by the submitter. The tool helps submitters know what documents and forms are required for IRB, as well as the type of IRB reviews and a Check for Completeness Assessment. The self-pre-review is not a required IRB form.
Investigator Assessment/Pre-Review Tool (updated 11/2019)
Note: Pre-review is designed to prepare submissions for IRB review and ensure the study meets criteria for review. While the expected outcome is approval of the submission, this is not a guaranteed outcome. Official review and determinations are made by the full board. The pre reviewed final submission will be stamped "pre-reviewed", however the submission must be received according to the submission instructions (described on the last page of the Investigator Self-Review Tool). Submission deadlines still apply for pre-reviewed studies that require a full board review.
If you are not sure that a project requires IRB review, use the following tool to describe the project and email to IRBQuestions@wayne.edu for assistance. Also, send any written proposal or data collections tools, if available.
Human Participant Research (HPR) Determination Tool (RCR update)
For information regarding activities that are not considered Human Participant Research please view the HPR Guidance Tool (4.2019 update).
Shortcuts to Forms
Always download the most current version of the forms from this website. If you submit an older version of the form, your submission will be returned to you.
Determining If IRB Review Is Required
Informed Consent Templates
Continuations & Status Check In Reports
Treatment Use (Investigational Drugs and Devices)
Unanticipated-Unexepected Problem and Adverse Event Reports
Shortcuts to Submission Requirements and Other Information
Veteran Affairs Medical Center (VAMC) Expedited and Full Board Review
- Medical/Behavioral Protocol Summary Form (updated 12/2018)
VAMC Submissions will continue to use the traditional submission process (see Protocol Summary Form for Instructions)
VAMC Exempt Review
- Exempt Research Categories
- Medical Exempt Protocol Summary Form (RCR update)
- Social/Behavioral/Education Exempt Protocol Summary Form (RCR update)
- Exempt Form Appendices (please complete the applicable appendix below based on the exempt category selection):
Other Initial Submissions
- Humanitarian Use Device (HUD) Form (04/2015)
- Administrative Application (04/2015)
- Authorization to Use Another IRB for Protocol Approval Agreement (04/2015)
- Authorization to be the IRB of Record for Collaborating Entity (04/2015)
- Appendix A - International Research (04/2015)
- Appendix B - Internet Use in Research (04/2015)
- Appendix C - Children as Research Participants (04/2015)
- Appendix D - Adult Research Participants with Impaired Decision Making Ability (RCR update) if applicable include with eProtocol submission
- Appendix E - Prisoners as Research Participants (04/2015)
- Appendix F - Use of Drugs, Biologic Agents, or Devices (04/2015) if applicable include with eProtocol submission
- Appendix G - Imaging/Diagnostic Radiation (04/2015) if applicable include with eProtocol submission
- Appendix H - The Use of Biological Specimens (RCR update) if applicable include with eProtocol submission
- Appendix I - Research Funded by a Component of the Department of Defense (DoD) (04/2015)
- Appendix J - Studies Conducted at or by the VA (04/2015)
- Appendix K - Pregnancy, Fetuses, Neonates (04/2015)
- Appendix L - NIH Genomic Data Sharing (04/2015)
- Institutional Certification: Genetic/Genomic Data Sharing
- Limited IRB Review Appendix M if applicable include with eProtocol submission
- Appendix N: Resumption of In-Person Clinical Research (NEW)
Additional Forms That May Be Required
- HIPAA Summary Form (04/2015)
- Additional Key Personnel List (New with esignature update 3/2020)
- Electronic Signature & Attestation (update 7/2020)
- Coordinating Center Application (04/2015) if applicable include with eProtocol submission under Study Location section
- WSU IRB Local Context Form (11/2019)
- Limited Data Set Data Use Agreement (revised 02/2019)
- VA Studies Documentation of Waiver of HIPAA Authorization for Research
Please note: For Data Use Agreements which are not Limited Data Set Data Use Agreements, please contact the MTA Assistant at firstname.lastname@example.org from the WSU's Technology Commercialization Office.
Data Use Agreements and Limited Data Sets IRB Guidance Tool (updated 6/26/2019)
Informed Consent Templates
Note: studies not approved via eProtocol must use the amendment forms listed here:
- Expedited Amendment Form (update 6/2020)
- Full Board Amendment Form (updated 6/2020) review the IRB Meeting and deadlines website for submission details
- Change in PI Form (04/2015)
- Key Personnel Change Form (correction 03/30/2020 electronic signature -open & save as an Adobe Acrobat document) (use the Additional Key Personnel List (New with esignature update 3/2020) if all key personnel changes cannot fit on the Key Personnel Change Form)
- Administrative Application (04/2015) - To Amend an Administrative Application
- Include any Appendices or Additional Forms, if necessary
eProtocol Amendment Submissions
- For Active protocols on the submitter's dashboard select "Start Amendment" and complete the amendment form
- See eProtocol Amendment submission guidance tool on the IRB Education website
All IRB approved research reviewed as expedited or by the full board requires either a continuation or closure before the date of expiration.
Studies not approved via eProtocol must use the Continuation Submission Form below.
Please submit continuations 6 weeks prior to the expiration date.
Single IRB Submissions 8-10 weeks prior to the expiration date.
- Continuation Submission Form (update 6.2020 previous version accepted until July 3, 2020)
- Revised Common Rule Transition Appendix (updated 3.2019)
- Administrative Application (04/2015) - To Continue/Renew an Administrative Application
eProtocol Continuation Submission
- For Active protocols on the submitter's dashboard select "Start continuing review" and complete the continuation form.
- See eProtocol submission guidance tools on the IRB Education website
Status Check-In: For Expedtied & Exempt submissions approved via the revised Common Rule a Status Check-In Report must be submitted to the IRB every 2 years. The Status Check-In Report must be submitted 6 weeks prior to the Status Check-In due date. Due dates are indicated on the initial IRB approval/concurrence memorandum. It is the PI's responsiblity to take note of this date and submit the Status Update report.
All IRB approved research reviewed as expedited or by the full board requires either a continuation or closure before the date of expiration.
Exempt studies that received Concurrence of Exemption after January 21, 2019 must submit a closure form or a Status-Check in report before the status due date.
For Paper-Base submissions complete the following closure form:
- Closure Form (updated 06/2020)
eProtocol Submissions Study Closure
To close an eProtocol study:
Complete the Final Report Form via eProtocol.
From the list of approved studies on your dashboard:
- click on the Protocol ID
- Select Start "Final Report Form"
- Complete the Final Report Preliminary Questions
- All Responses must be "Yes" for study closure eligibility
- Select "Continue" to complete the "Final Report Form"
- Single Time Emergency Use of a Test Article (Drug, Biologic or Device) Form (04/2015)
- Compassionate Use Form for Device Please use the new Expanded Access Submission Form (last date for accepting the Compassionate Use Form is 12/20/2019) Note: Compassionate Use does not apply to drugs
- NEW Expanded Access Form with digital signature (must open and safe as an Adobe Acrobat document for eSignature)
- Expanded Access Submission Form (10/2019) (word verson)
Contact the IRB Administration Offfice, HRPP director Monica Malian for assistance with these submissions (email@example.com)
(Unanticipated) Unexpected Problems and reportable Adverse Events must be reported to the IRB as soon as possible, but within 5 working days.
PLEASE ALSO USE THESE FORMS FOR eProtocol UP REPORTING
- Unanticipated Problems & Event Reporting Form (updated 8.2019 & correction 10.4.2019) Note: Title changed to "Unanticipated" For electronic submission, the Principal Investigator must sign the following Electronic Attestation & Signature Page . File must be opened and signed as an Adobe Acrobat document
- Unanticipated Problem Follow-up Form (updated 10/2019) previous version accepted until November 15, 2019
National Institutes of Health (NIH)
Effective October 1, 2017 NIH now automatically issues Certificates of Confidentiality (CoC) to all NIH funded or conducted research studies that are collecting or using identifiable, sensitive information (see Determining CoC Policy Applicability below). This policy is retroactive to December 13, 2016.
Questions Determining NIH CoC Policy Applicability
- Is the activity biomedical, behavioral, clinical, or other research?
If the answer to this question is no, then the activity is not issued a Certificate. If the answer is yes, then investigators will need to answer the following questions:
- Does the research involve Human Subjects as defined by 45 CFR Part 46?
- Are you collecting or using biospecimens that are identifiable to an individual as part of the research?
- If collecting or using biospecimens as part of the research, is there a small risk that some combination of the biospecimen, a request for the biospecimen, and other available data sources could be used to deduce the identity of an individual?
- Does the research involve the generation of individual level, human genomic data?
If the answer is yes to one the above questions the policy applies and NIH will automatically issue a CoC.
Submitting to the IRB
When the policy applies please include consent document(s) language provided with the CoC.
If the study is a NIH funded or conducted study please review the Determining Applicability questions. If the policy applies and a CoC is issued to investigators, an amendment should be submitted to the IRB with the updated consent language.
In addition, at the point of continuing review the IRB Administration Office will review NIH submissions to determine if certificate of confidentiality language is needed.
Extending or Amending Current CoC with NIH
Not sure if you need to extend or amend an existing CoC with NIH? View the NIH kiosk page on extending and amending an existing Certificate of Confidentiality.
Join our Listserv to keep up to date on changes to the forms, IRB training opportunities, policy changes, and other occasional announcements.
To Join send an email to: WSUIRBInfo@wayne.edu
Refer to the research categories below to determine if the research meets the requirements for an Exempt or Expedited approval. If the research does not meet requirements for either, then it should be submitted for Full Board review.
A letter of approval from the scientific review committee for research conducted at or by investigators from the following institutions or departments is required:
Detroit Medical Center (DMC), DMC Nursing Research Council, Karmanos Cancer Institute, Veterans Administration Medical Center, WSU Department of Psychiatry, and any other internal review that may be required by your department, but not by the IRB.
For more information on the DMC Research Review process, see: http://www.dmc.org/researchreviewprocess/
To check on the status of an IRB submission for expedited or exempt review, email firstname.lastname@example.org. Provide the project title and the PI name in the subject line. IRB memos will be sent (inter-office mail or post mail) and emailed approximately 7-10 business days following the review of the submission by the assigned IRB member.
To check on the status of an IRB submission for full board review, please wait to the end of the 10 business days after the IRB meeting date and email email@example.com. Provide the project title, the committee submitted to, and the PI name, in the subject line. IRB memos will be sent (inter-office mail or post mail) and emailed approximately 7-10 business days following the the date of the full board meeting.
Please note, in order to receive information about an IRB submission you must be listed on the study documents.